Dionysios Neofytos

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

Johan Maertens, Issam Raad, Kieren A. Marr et al. · The Lancet · 2015 · 938 citations

Antifungal Agent, Isavuconazole Versus Voriconazole, Antifungal Agents +7

Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry

Dionysios Neofytos, D. B. HORN, E. Anaissie et al. · Clinical Infectious Diseases · 2008 · 797 citations · Full text

Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients

Dionysios Neofytos, Jay A. Fishman, D. B. HORN et al. · Transplant Infectious Disease · 2010 · 441 citations

Transplantation, Contemporary Epidemiology, Fungal Pathogen +9

Epidemiology and Outcomes of Clostridium difficile Infections in Hematopoietic Stem Cell Transplant Recipients

Carolyn D. Alonso, S. Treadway, David B. Hanna et al. · Clinical Infectious Diseases · 2012 · 203 citations · Full text

Outcomes in Transplant Recipients Treated With Foscarnet for Ganciclovir-Resistant or Refractory Cytomegalovirus Infection

Robin K. Avery, Ravit Arav‐Boger, Kieren A. Marr et al. · Transplantation · 2016 · 160 citations · Full text